This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2004-2011.
Company Filing History:
Years Active: 2004-2011
Title: Keith Kwak: Innovator in Ubiquitin Ligase Research
Introduction
Keith Kwak is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of ubiquitin ligases. With a total of 6 patents to his name, Kwak's work has implications for therapeutic and diagnostic applications.
Latest Patents
One of Keith Kwak's latest patents involves the Human E3α ubiquitin ligase family. This invention relates to a novel polypeptide that encodes a protein, which is the full-length human ortholog of E3α ubiquitin ligase. The patent also covers vectors, host cells, antibodies, and recombinant methods for producing the polypeptide. Furthermore, it discloses various therapeutic, diagnostic, and research utilities for these and related products.
Career Highlights
Kwak is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative research that advances the understanding of ubiquitin ligases and their potential applications in medicine.
Collaborations
One of his notable coworkers is Hui-Quan Han, with whom he has collaborated on various projects related to their research interests.
Conclusion
Keith Kwak's contributions to the field of biotechnology, particularly through his patents on ubiquitin ligases, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic and diagnostic technologies.